Related Experiment Video
Updated: Jul 15, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Treatment of chronic venous insufficiency
Suman W Rathbun1, Angelia C Kirkpatrick
1Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, 920 Stanton L. Young Boulevard, WP 3120, Oklahoma City, OK 73104, USA. suman-rathbun@ouhsc.edu
Insights
Chronic venous insufficiency (CVI) is treated with compression therapy, which reduces venous hypertension and inflammation. While other treatments offer short-term relief, advanced endovascular and surgical options show promise for long-term improvement.
Area of Science:
- Vascular Medicine
- Phlebology
Background:
- Chronic venous insufficiency (CVI) stems from venous hypertension due to valvular reflux.
- This condition triggers pathological inflammatory processes and skin changes.
Purpose of the Study:
- To review current treatment modalities for CVI.
- To evaluate the efficacy of compression therapy, pharmacologic agents, herbal supplements, and endovascular/surgical interventions.
Main Methods:
- Review of existing literature on CVI treatments.
- Analysis of studies on compression therapy, pharmaceuticals, herbal extracts (e.g., horse chestnut), and endovascular/surgical procedures.
Main Results:
- Compression therapy is the primary treatment, effectively reducing venous hypertension and inflammation.
- Pharmacologic agents provide temporary symptom relief but lack long-term benefits.
- Herbal supplements like horse chestnut seed extract show short-term efficacy but require further validation.
- Endovascular and surgical techniques improve hemodynamics, promote ulcer healing, and enhance quality of life.
Conclusions:
- Compression therapy remains the cornerstone for managing CVI.
- Emerging endovascular treatments for varicose veins present promising therapeutic avenues.
Abstract:
Chronic venous insufficiency (CVI) results from venous hypertension secondary to superficial or deep venous valvular reflux. Treatment modalities are aimed at reducing venous valvular reflux, thereby inhibiting the ensuing pathologic inflammatory process. Compression therapy using pumps, bandaging, and/or graded compression stockings is the mainstay of treatment for CVI. Compression therapy has been shown to be effective in reducing venous hypertension retarding the development of inflammation and pathologic skin changes. Pharmacologic agents such as diuretics and topical steroid creams reduce swelling and pain short term but offer no long-term treatment advantage. Herbal supplements may reduce the inflammatory response to venous hypertension, but are not licensed by the US Food and Drug Administration, and vary in their efficacy, quality, and safety. However, several randomized controlled trials using the herbal horse chestnut seed extract containing aescin have shown short-term improvement in signs and symptoms of CVI. Endovascular and surgical techniques aimed at treatment of primary and secondary venous valvular reflux have been shown to improve venous hemodynamics promoting healing of venous ulcers and improving quality of life. The newer endovascular treatments of varicose veins using laser, radiofrequency ablation, and chemical foam sclerotherapy show some promise.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Varicose Veins I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease V: Postoperative Nursing Management
